BRCA1/2 testing in hereditary breast and ovarian cancer families II: Impact on relationships

被引:28
|
作者
McInerney-Leo, A
Biesecker, BB
Hadley, DW
Kase, RG
Giambarresi, TR
Johnson, E
Lerman, C
Struewing, JP
机构
[1] NHGRI, Med Genet Branch, Bethesda, MD 20892 USA
[2] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[3] Westat Res, Rockville, MD USA
[4] Johns Hopkins Biostat Ctr, Baltimore, MD USA
[5] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[6] NCI, Lab Populat Genet, Bethesda, MD 20892 USA
关键词
family cohesion; conflict; expressiveness; genetic counseling; cancer risk testing;
D O I
10.1002/ajmg.a.30566
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Members of hereditary breast and ovarian cancer (HBOC) families often express concern during genetic counseling about the impact of BRCA1/2 testing on close relatives. Yet whether there are likely to be adverse effects of either the decision to undergo genetic testing or the results of testing on family relationships is unknown. One purpose of this study was to assess the impact on close family relationships. Within a randomized trial of breast cancer genetic counseling methods, members of 13 HBOC families were offered BRCA1/2 testing for a known family mutation. The Family Relationship Index (FRI) of the Family Environment Scale (FES) was used to measure perceived family cohesion, conflict, and expressiveness at baseline and again 6-9 months following the receipt of test results, or at the equivalent time for those who declined testing. Participants (n = 212) completed baseline and follow-up questionnaires. Comparisons were made between testers and non-testers as well as between those who tested positive and negative for the family mutation. One hundred eighty-one participants elected to undergo genetic testing (85%) and 47 (26%) were identified to have a mutation. After adjusting for baseline family relationship scores, counseling intervention, gender and marital status, non-testers reported a greater increase in expressiveness (P = 0.006) and cohesion (P = 0.04) than testers. Individuals who tested positive reported a decrease in expressiveness (P = 0.07), although as a trend. Regardless of test decision or test result, those who were randomized to a client-centered counseling intervention reported a decrease in conflict (P = 0.006). Overall, study results suggest that undergoing genetic testing and learning ones BRCA1/2 status may affect family relationships. Those individuals who declined testing reported feeling closer to family members and more encouraged to express emotions to other family members demonstrating potential benefit from the offer of testing. Since those who tested positive reported feeling less encouraged to express their emotions within the family, we recommend helping clients to identify others with whom they feel comfortable sharing their thoughts and feelings about their positive gene status and increased cancer risk. Published 2005 Wiley-Liss, Inc.
引用
下载
收藏
页码:165 / 169
页数:5
相关论文
共 50 条
  • [1] BRCA1/2 testing in hereditary breast and ovarian cancer families: Impact on relationships
    Biesecker, BB
    McInerney-Leo, A
    Thompson, RE
    Hadley, D
    Kase, R
    Giambarresi, T
    Lerman, C
    Struewing, J
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 319 - 319
  • [2] Impact of genetic testing in breast/ovarian cancer (BRCA1) families
    Watson, M
    Lloyd, S
    Murday, V
    Ponder, B
    Averill, D
    Eeles, R
    PSYCHO-ONCOLOGY, 1996, 5 (04) : 361 - 361
  • [3] Hereditary breast/ovarian cancer families: beyond BRCA1 and BRCA2
    Fragoso, S.
    Santos, S.
    Mira, B.
    Machado, P.
    Luis, A.
    Clara, A.
    Opiniao, A.
    Bento, S.
    Miguel, I.
    Rodrigues, P.
    Parreira, J.
    Simoes, C.
    Vaz, F.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 568 - 568
  • [4] Indications for BRCA1 and BRCA2 mutation testing in hereditary breast and ovarian cancer families.
    Schmutzler, R
    Schwarz-Boeger, U
    Bastert, G
    Deininger, J
    Hahn, W
    Kast, K
    Prieshof, B
    Volm, T
    Kiechle, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 889S - 889S
  • [5] BRCA1/2 testing in hereditary breast and ovarian cancer families III:: Risk perception and screening
    McInerney-Leo, Aideen
    Hadley, Donald
    Kase, Ronald G.
    Giambarresi, Therese R.
    Struewing, Jeffery P.
    Biesecker, Barbara Bowles
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (20) : 2198 - 2206
  • [7] BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families.
    Schwarz-Boeger, U
    Schmutzler, RK
    Bastert, G
    Bender, HG
    Beckmann, MW
    Caffier, H
    Crohns, C
    Deininger, J
    Dietl, J
    Ditsch, N
    Distler, W
    Estevez-Schwarz, L
    Hepp, H
    Herroeder, N
    Huebbel, V
    Huettner, C
    Jackisch, C
    Jonat, W
    Kandel, M
    Kast, K
    Kaufmann, M
    Krapfl-Gast, AS
    Kreienberg, R
    Kuschel, B
    Kuschel, B
    Luck, H
    Meindl, A
    von Minckwitz, G
    Nestle-Kraemling, C
    Paepke, S
    Prieshof, B
    Rensing, K
    Rhiem, KA
    Schaeffer, MA
    Straub, L
    Untch, M
    Kiechle, T
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S154 - S155
  • [8] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
    Thomassen, Mads
    Hansen, Thomas V. O.
    Borg, Ake
    Lianee, Henriette Theilmann
    Wikman, Friedrik
    Pedersen, Inge Sokilde
    Bisgaard, Marie Luise
    Nielsen, Finn C.
    Kruse, Torben A.
    Gerdes, Anne-Marie
    ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777
  • [9] Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing
    Sun, Young
    Kang, Eunyoung
    Baek, Hyunnam
    Jung, Jaehag
    Hwang, Euijun
    Koo, Jauk
    Kim, Eun-Kyu
    Kim, Sung-Won
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (06) : 527 - 532
  • [10] Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families
    Biesecker, BB
    Ishibe, N
    Hadley, DW
    Giambarresi, TR
    Kase, RG
    Lerman, C
    Struewing, JP
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 93 (04): : 257 - 263